Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01093976Phase 2Completed
A Phase 2 trial of dronabinol in obsessive compulsive disorder (OCD), trichotillomania (TTM), Excoriation disorder (SPD), sponsored by University of Chicago. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01093976.